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Abstract
iNKT cells derive from CD4
+CD8
+ DP thymocytes, and are selected by thymocyte-thymocyte interactions through signals from
their invariant Va14-Ja18 TCR and from the costimulatory molecules SLAMF1 and SLAMF6. Genetic studies have demonstrated
the contribution of different signaling pathways to this process. Surprisingly, current models imply that the Ras/MAPK pathway,
one of the critical mediators of conventional ab T cell positive selection, is not necessary for iNKT cell development. Using mice
defective at different levels of this pathway our results refute this paradigm, and demonstrate that Ras, and its downstream
effectors Egr-1 and Egr-2 are required for positive selection of iNKT cells. Interestingly our results also show that there are
differences in the contributions of several of these molecules to the development of iNKT and conventional ab T cells.
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Introduction
Invariant NKT (iNKT) cells are a subset of ab T cells characterized
by the expression of an invariant Va14-Ja18 TCR (Va24-Ja18 in
humans). iNKT cells recognize lipid antigens presented by the non-
polymorphic, MHC I-like molecule, CD1d [1]. iNKT have been
implicated in multiple processes, including microbial immunity, tumor
rejection, autoimmunity, atherosclerosis and allergy [2,3].
iNKT cells develop in the thymus from CD4
+CD8
+ double
positive cells [2,4-6] and require the cooperative engagement of
the TCR and members of the signaling lymphocytic–activation
molecule (SLAM) family expressed on DP thymocytes [7]. Some of
the signaling pathways involved in iNKT development down-
stream of the TCR have been identified, including itk kinases [8],
NFkB [9,10], and Calcineurin [11].
The Ras/MAPK pathway plays a central role during ab Tc e l l s
positive selection [12,13] but it is thought to be dispensable for iNKT
cell development [14–16]. In fact, it is proposed that one of the roles
of SLAMs in positive selection of iNKT cells is to block activation of
Ras, by inducing recruitment and activation of Ras-GAP [14,15].
In this manuscript we present genetic evidence supporting a
critical role of Ras, and its downstream effectors Egr-1, Egr-2 for
positive selection of iNKT cells, suggesting that the signaling
pathways emanating from the TCR during positive selection of
conventional ab T cells and iNKT cells are similar.
Results
Generation of iNKT cells is blocked in dnRas transgenic
mice
The Ras/MAPK pathway plays a central role in the control of
positive selection of conventional ab T cells [12,13,17], but for a long
time, and based on one early report [16] it has been assumed that it
was not necessary for the generation of iNKT cells -see [14,15]-. Since
in the original paper NKT cell development had only been assessed
using NK1.1 staining in the thymus, we decided to revisit the possible
contribution of Ras to iNKT cell development using CD1d-tetramers.
We analyzed transgenic mice expressing a dominant negative Ras,
RasN17 [12], using PBS57-loaded CD1d tetramers to quantify iNKT
cells in the thymus, liver and spleen. As shown in Fig. 1. we found a
dramatic (,90%) decrease in the percentage and total numbers of
iNKT cells present in dnRas transgenic mice, suggesting that, despite
previous reports and the general consensus in the field, Ras plays a
central role in regulating positive selection of iNKT cells. The few
iNKT cells present in the thymus of dnRas mice accumulate in the
early immature populations (CD44
-NK1.1
- and CD44
+NK1.1
-)
(Fig 1C) where they are present at almost normal numbers (and
increased percentages), suggesting that the block in iNKT cell
development imposed by dnRas is at early stages of positive selection,
similar to its function during conventional ab T cell development.
During development of conventional ab T cells Ras has been
placed upstream of the transcription factors Egr and Id3 [13,18]. To
test whether expression of these transcription factors was also altered
in iNKT cell precursors we sorted CD1d tetramer positive, HSA
hi
(immature) and HSA
lo (mature) cells from wild type (WT) and dnRas
mice, and analyzed the expression of thesetranscription factors in the
different subsets. As shown in Fig. 1D, dnRas thymocytes have
decreased levels of Egr-1, Egr-2 and Id3, suggesting that a similar
signaling cascade is implicated in the development of iNKT cells.
Role of Egr1 and Egr2 in the generation of iNKT cells
The Egr family of transcription factors plays an important role
in many developmental checkpoints during T cell development. A
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in iNKT development, while Egr-1 was apparently dispensable [11].
G i v e no u rr e s u l t sw i t hd n R a s ,w ed e c ided to revisit these experiments.
F i r s tw ea n a l y z e di N K Tc e l ld e v e l o p m e n ti nE g r - 1k n o c k o u tm i c e .
As described [11], the percentages and totalnumbersof iNKTcellsin
the thymus, spleen and liver of these animals do not seem affected
(data not shown). However, because subtle defects may not be
apparent in a non-competitive situation, we decided to test the ability
of Egr-1
-/- thymocytes to give riseto iNKT cellsin a competitive bone
marrow chimera. Lethally irradiated CD45.1 hosts were reconstitut-
ed by a 1:1 mix of Lin
-bonemarrowcellsfromEgr-1
-/-(CD45.2) and
CD45.1/CD45.2 F1 C57B/6 mice. After 8-12 weeks the chimeras
were analyzed by flow cytometry to determine whether Egr-1
-/- DP
thymocytes could develop into iNKT cells in the presence of WT DP.
Our results (Fig. 2A) show that Egr-1
-/- thymocytes are significantly
less able to contribute to the iNKT lineage than WT thymocytes,
suggesting that the lack of phenotype in the Egr-1 knockout reflects
compensation by other family members, most likely Egr-2. A similar
result was observed in the liver population, while in the spleen the
contribution of WT and Egr1
-/- was not significantly different.
It was recently shown that Egr-2
-/- fetal liver cells are defective in
the generationof iNKT cells infetal liver chimeras [11]. To confirm
these results we used Egr-2
f/f-lck-Cre mice [19,20]. In these mice we
observed a significant (,50%) decrease in the percentages and
numbers of iNKT cells in thymus, liver and spleen (Fig. 2B). As in
the dnRas mice, there was an increase in the percentages of the
more immature population (CD44
-NK1.1
-) (Fig. 2C). This defect is
less profound that the defect reported in the fetal liver chimeras
[11], suggesting that there could be differences between fetal and
adult hematopoiesis in the contribution of different Egr family
members to the generations of iNKT cells. We also performed
competitive mixed bone marrow chimeras, and under these
conditions Egr-2
-/- thymocytes have very profound defects in the
generation of iNKT cells (data not shown).
Figure 1. dnRas mice lack iNKT cells. (a) Thymic profile of WT and dnRas mice (b) Percentages and absolute numbers of iNKT cells in the thymus
(T), spleen (S) and liver mononuclear cells (L) of normal littermate controls (WT) and dnRas mice stained with CD4, CD8, PBS57-loaded CD1d tetramer
and TCRb.( c) Percentages and absolute numbers of iNKT cell subpopulations in gated TCR
hiPBS57-CD1dtet
+ thymocytes from WT and dnRas mice.
Results representative of nine independent dnRas and WT pairs analyzed in five experiments, except for the CD44/NK1.1 histograms (n=2). The bar
graphs show the average and SEM of all the experiments. Significance as assessed using a two-tailed unpaired t-test. ***,0.001, **,0.01. (d) Gating
strategy used to sort the different populations. (e) Expression of Egr-1, Egr-2 and Id3 in sorted Tet
+ HSA
hi and Tet
+ HSA
lo from normal littermate
control (WT) and dnRas mice. Bar graphs show relative expression of dnRas compared to WT for three independent experiments. Each experiment
was an independent sort of a WT and dnRas pair. Expression in each experiment was normalized to the expression levelis in Tet
+ HSA
hi WT cells.
Significance as assessed using a two-tailed unpaired t-test. **,0.01.
doi:10.1371/journal.pone.0019890.g001
Figure 2. Egr1 and Egr2 contribute in a quantitatively different manner to iNKT cell development. (a) Contribution of WT and Egr1
-/-
(Egr1KO) cells to the iNKT compartment in thymus (T), spleen (S) and liver (L) of mixed bone marrow chimeras generated by injecting Egr1
-/- (CD45.2)
and F1(C57BL/6xB6-LY5.2/Cr) (CD45.1;CD45.2) bone marrow cells into lethally irradiated B6-LY5.2/Cr recipient mice (CD45.1). Mean and SEM is shown
on the right (n=5). Significance was assessed using a paired t-test. **,0.01, *,0.05. This is one out of two independent experiments. (b) Percentages
and absolute numbers of iNKT cells in the thymus (T), spleen (S) and liver mononuclear cells (L) of WT and Egr-2
f/f-lck-Cre (EGR2KO) mice stained with
CD4, CD8, PBS57-loaded CD1d tetramer and TCRb. (c) Percentages and absolute numbers of iNKT cell subpopulations in gated TCR-b
hiPBS57-
CD1dtet
+ thymocytes from WT and EGR2KO mice. Results representative of five independent pairs in three independent experiments. The bar graphs
show the average and SEM of all the experiments. Significance was assessed using an unpaired t-test. ***,0.001, **,0.01.
doi:10.1371/journal.pone.0019890.g002
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Egr-1 during the generation of iNKT cells. Since we have
previously shown that overexpression of Bcl-2 can rescue the
defect in positive selection of conventional ab T cells observed in
Egr2
f/f-lckCre mice [20], we decided to test whether Bcl-2 could
also rescue generation of iNKT cells. We infected bone marrow
Lin
- Sca
+c-Kit
+ Egr2
f/f-cre cells with a retrovirus encoding for a
Bcl2-GFP fusion protein [21], and adoptively transferred the
infected cells into lethally irradiated Ly5.1 recipients. The mice
were analyzed after 8 weeks, and the effect of Bcl-2 expression on
the development of T cells and iNKT was assessed by comparing
the percentages of TcR
high or CD1-tet
+ thymocytes in GFP
+
Egr2
f/f-Cre vs. GFP
- Egr2
f/f cells. As shown in Fig. 3, overex-
pression of Bcl-2 increased the percentage of Egr2
f/f-Cre TcR
hi
single positive cells, as previously described [20], but could not
rescue the defect in Egr2
f/f-Cre iNKT cells. These experiments
show that Bcl-2 is not sufficient to rescue development of the
iNKT cell lineage in mice with genetic defects in Egr-2, although
they do not discard its possible involvement. Furthermore, they
demonstrate that the signaling requirements for the development
of conventional ab T cells and iNKT cells are different.
To test whether the incomplete phenotype observed in the
Egr-2
f/f/lck-Cre mice was due to compensation by the related
transcription factor Egr-1, we bred Egr-2
f/f/lck-Cre mice to to
Egr-1
-/- mice, and analyzed the phenotype of the Egr-1, Egr-2 double
knockouts (DKO). As shown in Fig. 4, DKO mice have a very
profound defect in the number and percentages of iNKT cells in
thymus, spleen and liver, similar to that observed in dnRas mice.
Similarly to dnRas mice, there was an increase in the percentages of
the more immature population (CD44
-NK1.1
-)( F i g .4 C ) .T h e s e
results suggest that both Egr-1 and Egr-2 play a role in iNKT cell
development downstream Ras and calcineurin, although Egr-2 plays
a more important role here than Egr-1, in contrast with their similar
contributions to positive selection of conventional ab T cells.
Figure 3. Bcl-2 can not rescue the iNKT defect in Egr2KOmice. (a) Donor contributions in bone marrow chimeras generated by injecting MiG-
Bcl2 transduced Egr2
f/flck-Cre (Egr2KO) (CD45.2) and wild-type (CD45.1;CD45.2) cells into lethally irradiated CD45.1 recipients, analyzed at 8–12 weeks
(left), and a representative histogram of GFP expression in MiG-Bcl2 transduced Egr2KO thymocytes (right). (b) TcR thymic profiles (upper panel) and
iNKT cells frequency (lower panels) in wild-type, Egr2KO and Egr2KO-Bcl2 donor cells in the thymus (T) and Liver (L) of chimeras described in (a). (c)
Percentages of different cell subpopulations from WT Egr2KO and Egr2KO;Bcl-2 in the mixed bone marrow chimeras mice. Results representative of
eight independent chimeras in two independent experiments. The bar graphs show the average and SEM of all the experiments. Significance as
assessed using the unpaired t-test. ***,0.001.
doi:10.1371/journal.pone.0019890.g003
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have small defects in SLAM family members and CD1d
expression
Besides the signals mediated by the TCR-CD1d interaction,
development of iNKT cells requires additional signals initiated
by homophilic interactions of members of the SLAM family
-primarily SLAMF1 and SLAMF6 [7], and mediated by the
adaptor protein SAP [14,22–25]. To assess a possible role of
alterations in this pathway to the phenotype observed in dnRas
and Egr1,2 DKO mice, we determined whether expression of
these proteins was normal in DP thymocytes using flow cytometry.
As shown in Fig. 5A, the surface expression of SLAMF1, and
SLAMF6 is slightly decreased in DP thymocytes from dnRas mice
when compared with normal thymocytes. Other family members
expressed in thymocytes such as SLAMF3 and SLAMF5 are not
altered. Similarly we observed a small defect in CD1d expression
Figure 4. Egr1
-/-; Egr2
f/flckcre mice have a complete block in iNKT development. (a) Thymic profile of littermate wild-type (WT), or
Egr1
-/-;Egr2
f/flckcre (DKO) mice (b) Percentages and absolute numbers of iNKT cells in the thymus (T), spleen (S) and liver mononuclear cells (L) of WT
and EgrDKO mice stained with CD4, CD8, PBS57-loaded CD1d tetramer and TCRb. (c) Percentages and absolute numbers of iNKT cell subpopulations
in gated thymic TCR-bhiPBS57-CD1dtet
+ of WT and EgrDKO mice. Results representative of five independent pairs in three independent experiments.
The bar graphs show the average and SEM of all the experiments. Significance as assessed using the unpaired t-test. ***,0.001, **,0.01
doi:10.1371/journal.pone.0019890.g004
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PLoS ONE | www.plosone.org 5 May 2011 | Volume 6 | Issue 5 | e19890Figure 5. Defects in Slamf1, Slamf6 and CD1d expression in dnRas, but not Egr-1,2 double knockout mice. Slamf1, Slamf3, Slamf6,
Slamf5 and CD1d expression levels in DP thymocytes mice were assessed by flow cytometry. Shown are representative histograms, and the mean and
SEM of the normalized MFI of DP populations. In (A) WT vs. dnRas (n=5). In (B) WT vs. Egr1
-/-;Egr2
f/f-lck-Cre (Egr-DKO) (n=3). (C) SAP and BclxL
Ras and iNKT Cell Development
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molecules was not altered in Egr1,2 DKO DP thymocytes
(Fig. 5B). These results suggest that signaling through the
SLAM/SAP axis could be impaired in dnRas DP thymocytes,
and this could contribute to the positive selection defect.
Since the observed defect in expression of some SLAM family
members in dnRas DP thymocytes is similar to that observed in c-
Myb-deficient DP thymocytes [26], and in these cells there are also
defects in the expression of the signaling molecule SAP, and the
survival factor BclxL, we decided to analyze expression of these
molecules in dnRas mice. In contrast to c-Myb-deficient
thymocytes, expression of SAP and BclxL, assessed by intracellular
staining, was normal DP thymocytes from dnRas mice (Fig. 5C).
Discussion
Although it is known that the signaling mechanisms that control
iNKT cell development include a component derived from the
TCR-CD1d interaction, the pathways that mediate this effect
downstream the TCR are not completely understood. In this
report we characterize the central contribution of the Ras/MAPK
pathway to positive selection of the iNKT cell lineage, similar to its
described contribution to conventional ab T cell positive selection.
The Ras/MAPK pathway plays a central role during ab T cells
positive selection [12,13] but it is thought to be dispensable for
iNKT cell development [14–16]. In fact, it has been proposed that
one of the roles of SLAMs in positive selection of iNKT cells is to
block activation of Ras, by inducing recruitment and activation of
Ras-GAP [14,15]. The recent report that thymocytes defective in
Egr-2 had a defect in generation of iNKT cells [11] made us
reconsider the possible involvement of Ras in this process, since
Egr-2 induction downstream the TCR requires activation of both
Calcineurin and the Ras/MAPK pathway [27]. Our results clearly
show that defects in the Ras/MAPK pathway result in a dramatic
blockade in iNKT generation, with accumulation of immature
iNKT cell precursors (CD44
- NK1.1
-), suggesting a block in the
early stages of positive selection. This defect seems mediated by the
same downstream effectors as during conventional ab T cell
positive selection, because expression of Egr-2 and Id3 in
immature iNKT cell precursors is significantly decreased. It is
also possible that the defect in Ras/MAPK activation could
interfere with later stages of iNKT cell differentiation that involve
proliferation.
The Egr family of transcription factors plays an important role
in many developmental checkpoints during T cell development.
Although in some circumstances they can at least partially
compensate for each other, they are not completely redundant.
For example, during b-selection Egr-3 is the most important Egr
factor [28,29]. However, compound knockouts show that Egr1
also contributes in this stage [29]. Similarly, during positive
selection of conventional ab T cells, both Egr-1 and Egr-2
knockouts show a partial blockade in positive selection [20,30].
Our results show that, contrary to previous reports [11], both Egr-
1 and Egr-2 play a role during iNKT positive selection, although
the effect of Egr-1 is subtle, and is only uncovered in mixed bone
marrow chimeras, or in the Egr-1, Egr-2 double knockout animals,
which have a much more profound block in iNKT generation
than Egr-2 knockouts. It is also interesting that the defect we
observe in Egr-2
f/f lck-Cre mice is less profound than the defect
reported in the fetal liver chimeras from Egr-2
-/- mice [11]. This
could be due to differences between fetal and adult hematopoiesis
in the contribution of different Egr family members to the
generation of iNKT cells, or to an incomplete deletion of Egr-2 in
our conditional knockouts. However, we can not detect any Egr-2
message in sorted CD69
+ thymocytes in our mice, suggesting that
the deletion is very efficient. The molecular basis for the different
contribution of these two closely related transcription factors to
iNKT cell development remains an area of interest for future
studies.
An interesting difference between the dnRas and the Egr-1,
Egr-2 double knockout phenotypes is the observed small defect in
the expression of SLAMF1 and SLAMF6 in DP thymocytes from
dnRas mice. Given that these two members of the SLAM family
are critical for the development of iNKT cells [7], it is possible that
this decrease in SLAMF1 and SLAMF6 expression could also play
a role in the iNKT positive selection defect, similar to what we
demonstrated recently in c-Myb knockout mice [26]. However c-
Myb-defective thymocytes had also a defect in the expression of
SAP, the signaling molecule required downstream SLAMs [14,22-
25], and we did not observe any alterations in SAP expression in
dnRas thymocytes. Further experiments will be required to assess
the possible contribution of the SLAMF1 and SLAMF6 expression
defect to the iNKT cell selection phenotype.
In conclusion, in this manuscript we present genetic evidence
supporting a critical role of Ras, and its downstream effectors Egr-
1 and Egr-2 for positive selection of iNKT cells, suggesting that the
signaling pathways emanating from the TCR during positive
selection of conventional ab T cells and iNKT cells are similar. It
will be important to characterize how this signaling component
cooperates with signals derived from the SLAM/SAP axis to
initiate the molecular program that characterizes this lineage,
including expression of PLZF [31,32].
Materials and Methods
Ethics Statement
Mice were maintained in the Oklahoma Medical Research
Foundation (OMRF) AALAC accredited facility. All animals used
in this study received humane care in compliance with the
regulations relating to animals and all experiments involving
animals were approved by the Institutional Animal Care
Committee of OMRF (IACUC) (protocol #A0008).
Mice
dnRas [12], Egr1-deficient [28] and floxed Egr2 (Egr2
f/f) mice
[19] have been described. lck-Cre transgenic mice were from the
Jackson labs (Bar Harbor, ME). B6-LY5.2/Cr congenic mice
(CD45.1) were from NCI Frederick.
Flow cytometry
Cells were prepared, stained and analyzed as described [26].
iNKT cells were identified using murine CD1d tetramer loaded
with PBS57 [33] (NIH Tetramer Facility). For isolation of iNKT
HSA
hi and HSA
lo cells, total thymocytes from WT and dnRas
mice were incubated with APC-labeled CD1d-PBS57 tetramer,
and then magnetically enriched using anti-APC microbeads
expression levels in DP thymocytes from WT or dnRas mice were assessed by intracellular flow cytometry. Shown are representative histograms, and
the mean and SEM of the normalized MFI of DP populations (n=5). To normalize the MFI, we averaged the MFI for the WT mice in each experiment
and considered that value 1. The bar graphs show the average and SEM of all the experiments. Significance was assessed using the unpaired t-test
***,0.001, **,0.01 *,0.05.
doi:10.1371/journal.pone.0019890.g005
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PLoS ONE | www.plosone.org 7 May 2011 | Volume 6 | Issue 5 | e19890(Miltenyi Biotec Inc), as described [26]. Enriched iNKT cells were
then stained with CD1d-PBS57 tetramer, anti-TcR-b, and anti-
HSA, and sorted in a FACSAria (BD).
Intracellular staining
For intracellular BclxL staining, thymocytes were surface-stained
with CD4 and CD8, then fixed with 2% paraformaldehyde (Pella)
for 10 min at 37 ˚C, and washed in P4F (PBSx1, 4% FCS, 0.1%
sodium azide). Then cells were permeabilized with 0.1% Triton
X-100 (Calbiochem) in PBS for 15 min at room temperature,
washed twice with 1 ml P4F and stained with an Alexa FluorH
488-conjugated anti BclxL antibody (clone 54H6,Cell Signaling)
for 1 h at RT. Cells were washed and analyzed by flow cytometry.
Intracellular SAP staining was performed using BD Cytofix/
Cytoperm plus kit (Becton Dickinson), according with the
manufacturer’s instructions. The SAP antibody was a gift from
Dr. A. Veillette.
RT-PCR
Total RNA from sorted thymocytes was extracted using Qiagen
RNeasy mini kit according to the manufacturer’s protocol.
Reverse transcription (RT) was performed using Taqman reverse
transcription reagents (Applied Biosystems). 5 ng of cDNA was
used for each assay. SYBR Green real time PCR was performed
using a Biorad CFX96 Real-Time PCR detection system. Gene
specific forward (F) and reverse (R) primers were designed across
exon-exon junction using Primer Express software (Applied
Biosystems) with equivalent efficiency to the b-actin primers. Data
were analyzed using the comparative CT method using CFX
software (BioRad). The primers used were EGR1 Fw: 59-AGT
GGG AGC CGG CTG GAG AT-39 RV:59-GGG CGA TGT
AGC AGG TGC GG-39; EGR2 FW: 59-TTG ACC AGA TGA
ACG GAG TGG-39 RV 59- TGC CCA TGT AGG TGA AGG
TCT-39; ID3 FW 59-GAA GCC TGA GGG CAT GGA T-39 RV
59-CCT CGA GGC GTT GAG TTC A-39; b-Actin FW 59-CAA
CGA GCG GTT CCG ATG -39 RV 59-GCC ACA GGA TTC
CAT ACC CA-39.
Retroviral transduction of hematopoietic progenitors
Preparation of viral supernatant, purification and infection of
Lin
- progenitors was performed as described [20][34].
Generation of mixed bone marrow chimeras
Bone marrow cells were harvested from the femurs and tibiae
of F1 (C57BL/6 x B6-Ly5.2) (CD45.1/CD45.2), and Egr-1
-/-
(CD45.2). B6-LY5.2/Cr (CD45.1) recipient mice were lethally
irradiated with 1300 rad from a cesium source. A 1:1 mixture of
F1(CD45.1/CD45.2) and Egr-1
-/- (total of 1610
6 cell) bone
marrow cells were retro-orbitally injected into the hosts. Animals
were given antibiotic-containing water and housed in sterile
microisolator cages. Mice were analyzed eight to twelve weeks
after reconstitution.
Statistical Methods
Normal distribution of the data was assessed using the
Kolmogorov-Smirnov test. Depending on the results, statistical
significance was determined by the Student’s t test (for parametric
data) or by the Mann-Whitney test (for non-parametric data).
Acknowledgments
The authors thank Patrick Charnay (Institut National de la Sante ´e td el a
Recherche Me ´dicale, Paris, France), the NIH tetramer facility, and Andre
Veillette for providing reagents, and S. Kovats (Oklahoma Medical
Research foundation, Oklahoma City) for discussions.
Author Contributions
Conceived and designed the experiments: JAI DW. Performed the
experiments: TH IG AS. Analyzed the data: TG IG JAI. Contributed
reagents/materials/analysis tools: DW. Wrote the paper: JAI TH IG.
References
1. Godfrey DI, Berzins SP (2007) Control points in NKT-cell development. Nat
Rev Immunol 7: 505–518.
2. Matsuda JL, Mallevaey T, Scott-Browne J, Gapin L (2008) CD1d-restricted
iNKT cells, the ‘Swiss-Army knife’ of the immune system. Curr Opin Immunol
20: 358–368.
3. Taniguchi M, Tashiro T, Dashtsoodol N, Hongo N, Watarai H (2010) The
specialized iNKT cell system recognizes glycolipid antigens and bridges the
innate and acquired immune systems with potential applications for cancer
therapy. Int Immunol 22: 1–6.
4. Gapin L, Matsuda JL, Surh CD, Kronenberg M (2001) NKT cells derive from
double-positive thymocytes that are positively selected by CD1d. Nat Immunol
2: 971–978.
5. Bendelac A, Savage PB, Teyton L (2007) The biology of NKT cells. Annu Rev
Immunol 25: 297–336.
6. Kronenberg M, Engel I (2007) On the road: progress in finding the unique
pathway of invariant NKT cell differentiation. Curr Opin Immunol S 19:
186–193.
7. Griewank K, Borowski C, Rietdijk S, Wang N, Julien A, et al. (2007) Homotypic
interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage
development. Immunity 27: 751–762.
8. Felices M, Berg LJ (2008) The Tec kinases Itk and Rlk regulate NKT cell
maturation, cytokine production, and survival. J Immunol 180: 3007–3018.
9. Stanic AK, Bezbradica JS, Park JJ, Matsuki N, Mora AL, et al. (2004) NF-kappa
B controls cell fate specification, survival, and molecular differentiation of
immunoregulatory natural T lymphocytes. J Immunol 172: 2265–2273.
10. Stankovic S, Gugasyan R, Kyparissoudis K, Grumont R, Banerjee A, et al.
(2010) Distinct roles in NKT cell maturation and function for the different
transcription factors in the classical NF-kappaB pathway. Immunol Cell Biol 89:
294–303.
11. Lazarevic V, Zullo AJ, Schweitzer MN, Staton TL, Gallo EM, et al. (2009) The
gene encoding early growth response 2, a target of the transcription factor
NFAT, is required for the development and maturation of natural killer T cells.
Nat Immunol 10: 306–313.
12. Swan KA, Alberola-Ila J, Gross JA, Appleby MW, Forbush KA, et al. (1995)
Involvement of p21ras distinguishes positive and negative selection in
thymocytes. Embo J 14: 276–285.
13. Alberola-Ila J, Hernandez-Hoyos G (2003) The Ras/MAPK cascade and the
control of positive selection. Immunol Rev 191: 79–96.
14. Borowski C, Bendelac A (2005) Signaling for NKT cell development: the SAP-
FynT connection. J Exp Med 201: 833–836.
15. Godfrey DI, Stankovic S, Baxter AG (2010) Raising the NKT cell family. Nat
Immunol 11: 197–206.
16. Alberola-Ila J, Hogquist KA, Swan KA, Bevan MJ, Perlmutter RM (1996)
Positive and negative selection invoke distinct signaling pathways. J Exp Med
184: 9–18.
17. Alberola-Ila J, Forbush KA, Seger R, Krebs EG, Perlmutter RM (1995)
Selective requirement for MAP kinase activation in thymocyte differentiation.
Nature 373: 620–623.
18. Bain G, Cravatt CB, Loomans C, Alberola-Ila J, Hedrick SM, et al. (2001)
Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK
MAPK cascade. Nat Immunol 2: 165–171.
19. Taillebourg E, Buart S, Charnay P (2002) Conditional, floxed allele of the
Krox20 gene. Genesis 32: 112–113.
20. Lauritsen JP, Kurella S, Lee SY, Lefebvre JM, Rhodes M, et al. (2008) Egr2 Is
Required for Bcl-2 Induction during Positive Selection. J Immunol 181:
7778–7785.
21. Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, et al. (1997) Movement
of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 139:
1281–1292.
22. Nichols KE, Hom J, Gong SY, Ganguly A, Ma CS, et al. (2005) Regulation of
NKT cell development by SAP, the protein defective in XLP. Nat Med 11:
340–345.
23. Pasquier B, Yin L, Fondaneche MC, Relouzat F, Bloch-Queyrat C, et al. (2005)
Defective NKT cell development in mice and humans lacking the adapter SAP,
the X-linked lymphoproliferative syndrome gene product. J Exp Med 201:
695–701.
Ras and iNKT Cell Development
PLoS ONE | www.plosone.org 8 May 2011 | Volume 6 | Issue 5 | e1989024. Chung B, Aoukaty A, Dutz J, Terhorst C, Tan R (2005) Signaling lymphocytic
activation molecule-associated protein controls NKT cell functions. J Immunol
174: 3153–3157.
25. Eberl G, Lowin-Kropf B, MacDonald HR (1999) Cutting edge: NKT cell
development is selectively impaired in Fyn- deficient mice. J Immunol 163:
4091–4094.
26. Hu T, Simmons A, Yuan J, Bender TP, Alberola-Ila J (2010) The transcription
factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the
iNKT lineage. Nat Immunol 11: 435–441.
27. Shao H, Kono DH, Chen LY, Rubin EM, Kaye J (1997) Induction of the early
growth response (Egr) family of transcription factors during thymic selection.
J Exp Med 185: 731–744.
28. Xi H, Kersh GJ (2004) Early growth response gene 3 regulates thymocyte
proliferation during the transition from CD4-CD8- to CD4+CD8+1. J Immunol
172: 964–971.
29. Carter JH, Lefebvre JM, Wiest DL, Tourtellotte WG (2007) Redundant role for
early growth response transcriptional regulators in thymocyte differentiation and
survival. J Immunol 178: 6796–6805.
30. Bettini M, Xi H, Milbrandt J, Kersh GJ (2002) Thymocyte development in early
growth response gene 1-deficient mice. J Immunol 169: 1713–1720.
31. Verykokakis M, Boos MD, Bendelac A, Adams EJ, Pereira P, et al. (2010)
Inhibitor of DNA binding 3 limits development of murine slam-associated
adaptor protein-dependent ‘‘innate’’ gammadelta T cells. PLoS One 5: e9303.
32. Alonzo ES, Gottschalk RA, Das J, Egawa T, Hobbs RM, et al. (2010)
Development of promyelocytic zinc finger and ThPOK-expressing innate
gamma delta T cells is controlled by strength of TCR signaling and Id3.
J Immunol 184: 1268–1279.
33. Liu Y, Goff RD, Zhou D, Mattner J, Sullivan BA, et al. (2006) A modified alpha-
galactosyl ceramide for staining and stimulating natural killer T cells. J Immunol
Methods 312: 34–39.
34. Hernandez-Hoyos G, Alberola-Ila J (2005) Analysis of T-cell development by
using short interfering RNA to knock down protein expression. Methods
Enzymol 392: 199–217.
Ras and iNKT Cell Development
PLoS ONE | www.plosone.org 9 May 2011 | Volume 6 | Issue 5 | e19890